<DOC>
	<DOCNO>NCT00109330</DOCNO>
	<brief_summary>This study evaluate safety immune response GlaxoSmithKline Tdap vaccine compare licensed Td vaccine use booster healthy adolescent ( 10-18 year age ) .</brief_summary>
	<brief_title>A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine</brief_title>
	<detailed_description>A combined Tdap ( Tetanus , Diphteria , Acellular Pertussis ) Vaccine Used Booster compare Licensed Td ( Tetanus Diphteria ) vaccine</detailed_description>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy adolescent history complete routine vaccination diphtheria , tetanus , pertussis ( DTP ) . Use investigational drug vaccine 30 day precede study vaccination . Chronic administration immunosuppressant . Administration preschool DTP vaccine within previous 5 year . Administration Td booster within previous 10 year .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Prevention Diphtheria , Tetanus , Pertussis</keyword>
</DOC>